Table 6.
Mean German semi-quantitative scoring of immunohistochemical staining of primary tumor phosphorylation and AMPKα protein expression in association with biopsy total Gleason score.
| Biopsy Total Gleason Score | ||||||
|---|---|---|---|---|---|---|
| 6 (n=17) | 7 (n=29) | 8 (n=10) | 9 (n=17) | 10 (n=2) | p-value | |
| p-Ser-486/491 AMPKα | 1.94 | 2.50 | 4.00 | 5.54 | 9.00 | 0.002** |
| p-Thr-172 AMPKα | 1.65 | 2.09 | 2.00 | 2.62 | 3.00 | 0.870 |
| AMPKα | 5.71 | 7.27 | 8.25 | 7.46 | 7.50 | 0.843 |
| p-Ser-79 ACC | 2.06 | 3.27 | 0.00 | 1.46 | 0.00 | 0.078 |
| p-Ser-872 HMG-CoAR | 10.53 | 11.27 | 10.25 | 5.62 | 3.50 | 0.014* |
| p-Ser-792 Raptor | 3.88 | 3.91 | 4.50 | 1.77 | 8.00 | 0.211 |
AMPKα, adenosine monophosphate (AMP)-activated protein kinase, alpha catalytic subunit; ACC, acetyl-CoA carboxylase; HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase. No statistical distinction was found between Gleason 3+4=7 and 4+3=7 prostate cancer.
p < 0.05;
p < 0.01 determined by Cochran-Armitage test for trend.